Muriel Debois

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa et al. · The Lancet Oncology · 2016 · 489 citations · Full text

Oncology, Immunology, Bronchial Neoplasm +8

Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891

Urs E. Studer, Peter Whelan, Walter Albrecht et al. · Journal of Clinical Oncology · 2006 · 330 citations

Long-term Survival and Metastatic Pattern of Pancreatic and Periampullary Cancer After Adjuvant Chemoradiation or Observation

Hans G. Smeenk, Casper H.J. van Eijck, Wim C.J. Hop et al. · Annals of Surgery · 2007 · 316 citations

Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer

Cora N. Sternberg, Peter Whelan, John Hetherington et al. · Oncology · 2005 · 201 citations

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Brigitte Dréno, John F Thompson, B. Mark Smithers et al. · The Lancet Oncology · 2018 · 190 citations

Tumor Immunology, Cancer Immunosurveillance, Medicine +11